SCOTTSDALE, ARIZ – March 29, 2023 – Aural Analytics, Inc., a leader in clinical-grade speech analytics, today announced that its Speech Vitals – ALS technology has been granted designation as a Breakthrough Device by the US Food and Drug...
In a clinical trial evaluating Pridopidine vs. placebo in adults with ALS, Aural Analytics’s speech analytics platform suggested slowing of decline in several markers related to speech and bulbar function in participants taking Pridopidine, while the primary endpoint...
Aural Analytics achieves “gold standard” ISO certifications directly following FDA registration, deepening its commitment to the highest quality clinical-grade speech analytics on the market PHOENIX – November 10, 2022 – Aural Analytics, Inc.,...
Aural Analytics obtains FDA registration to improve the standard of care and lead the way for speech analytics in clinical settingsas a Computerized Cognitive Assessment Aid PHOENIX – October 25, 2022 – Aural Analytics, Inc., a leader in clinical-grade...
The future of concussion protocol: real-time app-based concussion assessment helps in game time concussion decisions PHOENIX, ARIZ – October 18, 2022 – Aural Analytics, Inc., a leader in clinical-grade speech analytics, today announced a partnership with...
New study aims to demonstrate the efficacy of speech analysis in the early detection of ALS PHOENIX, ARIZ. – September 20, 2022 – Aural Analytics, Inc., a leader in clinical-grade speech analytics, today announced it was chosen for EverythingALS’ upcoming 12-month...